Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Toward the end of trading Monday, the Dow traded up 1.09% to 27734 while the NASDAQ fell 0.45% to 10961.67. The S&P also rose, gaining 0.17% to 3,356.99.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 5,045,560 cases with around 162,930 deaths. Brazil confirmed a total of over 3,035,420 COVID-19 cases with 101,040 deaths, while India reported a total of at least 2,215,070 confirmed cases and 44,380 deaths. In total, there were at least 19,876,300 cases of COVID-19 worldwide with over 731,570 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Energy shares gained 2.5% on Monday. Meanwhile, top gainers in the sector included Penn Penn Virginia Corporation (NASDAQ:PVAC), up 17%, and Peabody Energy Corporation (NYSE:BTU), up 12%.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
In trading on Monday, communication services shares fell by 0.6%.
Top Headline
Marriott International Inc (NASDAQ:MAR) reported a wider-than-expected loss for its second quarter, while sales missed views.
Marriott International posted a Q2 loss of $0.64 per share, wider than analysts’ estimates for a loss of $0.42 per share. The company reported quarterly sales of $1.46 billion, missing expectations of $1.68 billion.
Equities Trading UP
Seres Therapeutics, Inc. (NASDAQ:MCRB) shares shot up 346% to $20.70 after the company announced the results from its SER-109 Phase 3 ECOSPOR III study in recurrent C. difficile infection met the primary endpoint.
Shares of Omeros Corporation (NASDAQ:OMER) got a boost, shooting 55% to $21.87 after the biopharma announced results from a compassionate use study of its lead investigational human monoclonal antibody. Omeros said its narsoplimab, when administered to six COVID-19 patients with Acute Respiratory Distress Syndromewho initially required mechanical ventilation, led to recovery, survival and discharge from the hospital.
Trevena, Inc. (NASDAQ:TRVN) shares were also up, gaining 27% to $3.0250 after the company disclosed that the FDA has approved its OLINVYK injection.
Equities Trading DOWN
FREE REPORT: How To Learn Options Trading Fast
In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.
Eastman Kodak Company (NYSE:KODK) shares tumbled 28% to $10.67. The federal government is halting a $765 million loan to Eastman Kodak for its generic drug-making foray until the company is cleared of insider trading allegations.
Shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA) were down 33% to $105.39 following Q2 results. Reata Pharmaceuticals posted a Q2 loss of $1.23 per share on revenue of $3.07 million.
Navidea Biopharmaceuticals, Inc. (NYSE:NAVB) was down, falling 28% to $3.42 after the company signed binding framework for commercialization partnership with Jubilant Radiopharma. The company also secured $25 million of committed financing.
Commodities
In commodity news, oil traded up 2.3% to $42.17, while gold traded up 0.6% to $2,041.00.
Silver traded up 6.6% Monday to $29.37, while copper rose 2.7% to $2.8685.
Euro zone
European shares closed higher today. The eurozone’s STOXX 600 rose 0.3%, the Spanish Ibex Index rose 1.49%, while Italy’s FTSE MIB Index gained 0.69%. Meanwhile, the German DAX 30 gained 0.10%, French CAC 40 rose 0.41% and UK shares rose 0.31%.
Economics
The number of job openings rose by 518,000 to 5.9 million in June, exceeding analysts’ estimates of 4.91 million.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.